Core Laboratories NV (CLB):企業の財務・戦略的SWOT分析

◆英語タイトル:Core Laboratories NV (CLB) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDGE35291FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年2月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:Oil and Gas
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥43,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Core Laboratories NV (CLB) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Core Laboratories NV (Core Lab) is an oil and gas service provider. It offers patented and proprietary reservoir description and reservoir management services. Core Lab’s portfolio includes inspection, testing and calibration, core analysis, reservoir fluid analysis, instruments, integrated reservoir solutions and others. The company provides services to major national and independent oil companies. The company also provides laboratory equipment to client company research labs, universities and government institutes. Core Lab’s patented technologies include SpectraChem, SpectraFlood, SMAX, PACKSCAN, SuperHERO, SuperHERO Plus, X-SPAN, ZERO WASH and GTX-SPAN among others. Operationally, the company has global presence in various countries including the US and Canada. Core Lab is headquartered in Amsterdam, the Netherlands.

Core Laboratories NV Key Recent Developments

Jan 27,2021: Core Lab reports fourth quarter and full year 2020 results from continuing operations
Oct 21,2020: Core Lab reports Third quarter 2020 results from continuing operations
Jul 22,2020: Core Lab reports second quarter 2020 results from continuing operations
Apr 22,2020: Core Lab Reports First Quarter 2020 Results From Continuing Operations:
Mar 16,2020: Core Lab announces reduced dividend and expansion of cost reduction initiatives

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Core Laboratories NV – Key Facts
Core Laboratories NV – Key Employees
Core Laboratories NV – Key Employee Biographies
Core Laboratories NV – Major Products and Services
Core Laboratories NV – History
Core Laboratories NV – Company Statement
Core Laboratories NV – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Core Laboratories NV – Business Description
Business Segment: Production Enhancement
Overview
Performance
Business Segment: Reservoir Description
Overview
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Canada
Performance
Geographical Segment: Europe/Africa/ Middle East
Performance
Geographical Segment: Former Soviet Union
Performance
Geographical Segment: Latin/ South America
Performance
Geographical Segment: United States
Performance
Core Laboratories NV – Corporate Strategy
Core Laboratories NV – SWOT Analysis
SWOT Analysis – Overview
Core Laboratories NV – Strengths
Core Laboratories NV – Weaknesses
Core Laboratories NV – Opportunities
Core Laboratories NV – Threats
Core Laboratories NV – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Oil & Gas Financial Deals and Alliances
Core Laboratories NV, Oil & Gas, Deals By Year, 2015 to YTD 2021
Core Laboratories NV, Oil & Gas, Deals By Type, 2015 to YTD 2021
Core Laboratories NV, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 27, 2021: Core Lab reports fourth quarter and full year 2020 results from continuing operations
Oct 21, 2020: Core Lab reports Third quarter 2020 results from continuing operations
Jul 22, 2020: Core Lab reports second quarter 2020 results from continuing operations
Apr 22, 2020: Core Lab Reports First Quarter 2020 Results From Continuing Operations:
Mar 16, 2020: Core Lab announces reduced dividend and expansion of cost reduction initiatives
Jan 29, 2020: Core Lab Reports Fourth Quarter 2019 Results From Continuing Operations
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Core Laboratories NV, Key Facts
Core Laboratories NV, Key Employees
Core Laboratories NV, Key Employee Biographies
Core Laboratories NV, Major Products and Services
Core Laboratories NV, History
Core Laboratories NV, Subsidiaries
Core Laboratories NV, Key Competitors
Core Laboratories NV, Ratios based on current share price
Core Laboratories NV, Annual Ratios
Core Laboratories NV, Annual Ratios (Cont...1)
Core Laboratories NV, Annual Ratios (Cont...2)
Core Laboratories NV, Interim Ratios
Core Laboratories NV, Oil & Gas, Deals By Year, 2015 to YTD 2021
Core Laboratories NV, Oil & Gas, Deals By Type, 2015 to YTD 2021
Core Laboratories NV, Recent Deals Summary
Currency Codes
Units
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Core Laboratories NV (CLB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SSA Marine Inc:企業の戦略的SWOT分析
    SSA Marine Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Swisscom, Ltd.:企業のM&A・事業提携・投資動向
    Swisscom, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swisscom, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Singulex Inc-医療機器分野:企業M&A・提携分析
    Summary Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and p …
  • SK Chemicals Co Ltd (006120):企業の財務・戦略的SWOT分析
    Summary SK Chemicals Co Ltd (SK Chemicals) is a provider of chemical and pharmaceutical products. The company offers pharmaceutical drugs to treat erectile dysfunction, arthritis, peptic ulcer, gastroesophageal reflux disease (GERD), cancer and to improve blood circulation. It manufactures green che …
  • Laureate Education, Inc.:企業のM&A・事業提携・投資動向
    Laureate Education, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Laureate Education, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Applied DNA Sciences Inc (APDN):企業の財務・戦略的SWOT分析
    Summary Applied DNA Sciences Inc (APDN) is a biotechnology company that provides DNA based security and authentication solutions and services. The company offers products such as DNA security tools, DNA marking kit for assets and valuables, test kits, intruder and offender tagging systems; custom DN …
  • Sodexo SA:企業のM&A・事業提携・投資動向
    Sodexo SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sodexo SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Marina Biotech, Inc.:企業の戦略・SWOT・財務情報
    Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Pasteur Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Pasteur Institute is a non-profit foundation that provides research, health services and teaching services. The foundation conducts research in the areas of biology, genomes and genetics, immunology, infection and epidemiology, microbiology, neuroscience, parasitology and mycology, structura …
  • Fondazione Telethon:製薬・医療:M&Aディール及び事業提携情報
    Summary Fondazione Telethon (Telethon) is a non-profit healthcare organization that funds and invests for projects in the area of biomedical research on genetic diseases. The organization develops projects by offering support services for increasing the horizons of therapeutic application to new res …
  • Arthur J. Gallagher & Co:企業のM&A・事業提携・投資動向
    Arthur J. Gallagher & Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Arthur J. Gallagher & Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Frontier Communications Corporation:企業の戦略・SWOT・財務情報
    Frontier Communications Corporation - Strategy, SWOT and Corporate Finance Report Summary Frontier Communications Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • BG Medicine Inc:医療機器:M&Aディール及び事業提携情報
    Summary BG Medicine Inc (BGM), formerly Beyond Genomics Inc is a medical device company that discovers, develops and delivers diagnostic products. The company offers diagnostis products to aid in the clinical management of heart failure and related disorders. It offers BGM Galectin-3 test, an in vit …
  • Sonangol EP:企業のM&A・事業提携・投資動向
    Sonangol EP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sonangol EP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • HRG Group, Inc. (HRG):企業の財務・戦略的SWOT分析
    HRG Group, Inc. (HRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Retrophin Inc (RTRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Retrophin Inc (Retrophin) is a biopharmaceutical company that discovers, develops, acquires and commercializes drugs for the treatment of rare diseases. The company’s products include thiola, chenodal and cholbam. It develops drugs for various catastrophic diseases. Retrophin’s pipeline prod …
  • Kyushu Financial Group Inc (7180):企業の財務・戦略的SWOT分析
    Kyushu Financial Group Inc (7180) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • 23andMe Inc:医療機器:M&Aディール及び事業提携情報
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. Its service portfolio includes clinical development, research and development, ancestry service …
  • Cowen Inc:企業のM&A・事業提携・投資動向
    Cowen Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cowen Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Phibro Animal Health Corp (PAHC):企業の財務・戦略的SWOT分析
    Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆